Navigation Links
Remarks by President Bush on Stem Cell Veto and Executive Order

his one are important and should give us hope that there's a better way forward than scientific advances that require the destruction of a human life.

The researchers pursuing these kinds of ethically responsible advances deserve our support, and there is legislation in Congress to give them that support. Recently, the United States Senate passed a bill sponsored by Norm Coleman and others that would authorize additional federal funding for alternative stem cell research. The bill was approved with the backing of 70 United States senators. The House leaders need to pass similar legislation that would authorize additional funds for ethical stem cell research. That would be an important advancement. It would be an important statement. Because we can't lose the opportunity to conduct research that would give hope to those suffering from terrible diseases -- and help this country move beyond the controversies over embryo destruction.

We have a good chance to put aside all the politics and focus on a good piece of legislation that advances science and doesn't cross an ethical line. Norm, I want to thank you and Johnny Isakson for sponsoring that piece of legislation. (Applause.)

In the meantime, my administration is taking immediate action to increase our support for researchers in their vital work. Earlier today, I issued an executive order to strengthen our nation's commitment to research on pluripotent stem cells. This order takes a number of important steps. The order directs the Department of Health and Human Services and the NIH to ensure that any human pluripotent stem cell lines produced in ways that do not create, destroy, or harm human embryos will be eligible for federal funding.

The order expands the NIH Embryonic Stem Cell registry to include all types of ethically produced human pluripotent stem cells. The order renames the registry -- calls it this, the Pluripotent Stem Cell Registry -- so it reflects what stem cells can do, ins
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. President Bush Ignores Americas Plea for Support of Stem Cell Research
2. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
3. Dean: President Bush Has Turned His Back on the American People

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Remarks President Bush Stem Cell Veto and Executive Order
(Date:11/25/2009)... , COLLEGE PARK, Md., Nov. 25 /PRNewswire-USNe...eveloping a shaving cream-like foam that stops sev...ost Promising Security Idea category of the Global...ce today. ,, Selected from more than 100 entrie...heir invention at the GSC Security Summit conferen...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Repor...eport is available in its catalogue: ,, Mammo..., http://www.reportlinker.com/p0164330/Mammogr... ,, Rising incidence of breast cancer in indust...pal factor influencing growth in the mammography m...
(Date:11/25/2009)... , CHAPEL HILL, N.C., Nov. 25 /PRNewswire/ -... Prabhavathi Fernandes, president and chief execut...t Annual Health Care Conference at 8:50 a.m. EST, ...New York City. Dr. Fernandes will provide an over...cal programs for the treatment of drug-resistant p...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Nuvilex to Issue Positive Shareholder Newsletter 55318 1Nuvilex to Issue Positive Shareholder Newsletter 55318 2Nuvilex to Issue Positive Shareholder Newsletter 55318 3Nuvilex to Issue Positive Shareholder Newsletter 55318 4Nuvilex to Issue Positive Shareholder Newsletter 55318 5NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 1NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 2NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 3NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 4Tamoxifen May Up Risk of Second More Aggressive Breast Cancer 55316 1Tamoxifen May Up Risk of Second More Aggressive Breast Cancer 55316 2
...IPPANY, N.J. and NEW YORK, Oct. 12 Daiichi Sankyo...announced today that they,have signed a contract f...or Daiichi Sankyo,s AZOR(TM), a fixed combination ...ker, amlodipine and the,angiotensin receptor block...a signed letter of intent for the co-promotion agr...
...lete Data to be Submitted for Presentation at 2007...cer Symposium, REDWOOD CITY, Calif., Oct. 11 Gen...encouraging results from a study of,Oncotype DX in...receptor,positive breast cancer conducted by the S...Institute clinical trials cooperative group. Oncot...
Other Medicine Technology:Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM) 2Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM) 3Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM) 4Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients 2Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients 3
(Date:11/27/2009)... FRANCISCO, Nov. 27 The ...at Blair Lambert, CFO/COO, will present at the NAS...at the May Fair Hotel in London, England, on Wedne...o listen to a live broadcast of The Gymboree Corpo...g on to www.gymboree.com, click on "Our Company" a...
(Date:11/27/2009)... XenaCare Holdings has announced that i...oundation, one of the largest nonprofit organizati...lth education. , Delray B...dings, Inc. (OTCBB: XCHO), a company specializing ...er healthcare products, has announced today that i...
(Date:11/27/2009)... Voyant Health™ announced today t...icensed its TraumaCad Enterprise orthopedic templa...lution. , (PRWEB) Novembe... that Spectrum Health (Grand Rapids, Michigan) has...lating solution and its TraumaCad Extend workflow ...
(Date:11/26/2009)...W YORK, Nov. 27 With cold and flu ...mploy good practices to control the spread of infe...active not only to keep ourselves healthy, but to ...leen Finerty, RN, MS, CIC (certified in infection-...nd occupational health at Hospital for Special Sur...
(Date:11/26/2009)... too big or too heavy can lead to strains or worse...-- There may be nothing wrong with stuffing your t...do the same thing with your suitcase as you pack f...e treated in 2008 in U.S. hospital emergency rooms...lities for luggage-related injuries, such as muscl...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2
...ry is set to get a further boost with two companie...dicare facilities overseas//. Global Medicare...vel, a leading travel firm, have signed an agreeme...p 40 recognised hospitals and promote their expert...
...nes on obesity finalized to cause harm to children...//. Due to financial agreements made between...oting this proposal, an unfit guideline was being ...merican Medical Association has ‘tentatively decid...
...o act fast when their reputation is at stake. Now ...rand credibility by doing something solid about al... Chicken, Wendy's, McDonald's and Burger King are ...tent. Jeff O'Neill, president and chief oper...
...ll portion of the horses in the Meath/Kildare regi...ing to reports from The Department of Agriculture ...uine Infectious Anemia, has an incubation period o...ons are being conducted to ascertain the facts. Th...
...ol of Medicine have found that very few women cons...apies and soy products to treat their menopausal s...ecause growing numbers of women are turning to alt...ated with hormone therapy, which is still consider...
...oronary artery disease is to induce hearts to rege...nd damaged tissue. // Unfortunately, clinical tri...ood vessel growth factors, fibroblast growth facto... Medicine in St. Louis have investigated a third s...
Other Medicine News:Health News:Plan to Promote the Medicare Facilities of India to Abroad 2Health News:New Obesity Guidelines Will Trouble US Children 2Health News:Treatment of Menopausal Symptoms Without Consulting Doctors 2Health News:Treatment of Menopausal Symptoms Without Consulting Doctors 3Health News:Treatment of Menopausal Symptoms Without Consulting Doctors 4Health News:Growth Factor Aids in Regeneration of Heart Blood Vessel 2
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: